S&P 500 Up on Coronavirus Vaccine Trials, Amazon Upgrade, Chevron-Noble Merger

Another day of positive results from a prospective coronavirus vaccine and an upgrade for a tech giant lifted the S&P 500 Index (SNPINDEX: ^GSPC) 27 points, or 0.8% on Monday. According to a report in a major medical journal, AstraZeneca's (NYSE: AZN) AZD1222 vaccine candidate reported positive results in an early stage trial, while the stock of Amazon (NASDAQ: AMZN) got a huge upgrade from analysts at Goldman Sachs (NYSE: GS), lifting shares of the $1.5 trillion company an incredible 8%. 

We're also getting a big merger in the oil patch. Integrated oil giant Chevron (NYSE: CVX) is buying smaller producer Noble Energy (NASDAQ: NBL) in a deal valued at $13 billion. This marks one of the first big deals since oil demand and prices crashed earlier this year, and offers evidence that executives still see value to be had in the oil patch. 

Image source: Getty Images.

Continue reading

Source Fool.com